Listed

Koninklijke Philips NV: Form 20-F for the period ended Dec 31, 2021

Filed with the SEC on Feb 22, 2022 and accepted by EDGAR at Feb 22, 2022, 07:30 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2021-01-01 to 2021-12-31EUR 17.16bnifrs-full:Revenue
Cost of revenue12 months2021-01-01 to 2021-12-31EUR 9.99bnifrs-full:CostOfSales
Gross profit12 months2021-01-01 to 2021-12-31EUR 7.17bnifrs-full:GrossProfit
Operating income12 months2021-01-01 to 2021-12-31EUR 553.0mifrs-full:ProfitLossFromOperatingActivities
Income tax12 months2021-01-01 to 2021-12-31−EUR 103.0mifrs-full:IncomeTaxExpenseContinuingOperations
Net income12 months2021-01-01 to 2021-12-31EUR 3.32bnifrs-full:ProfitLossAttributableToOwnersOfParent
Diluted EPS12 months2021-01-01 to 2021-12-31EUR 3.65ifrs-full:DilutedEarningsLossPerShare
Basic EPS12 months2021-01-01 to 2021-12-31EUR 3.67ifrs-full:BasicEarningsLossPerShare
Capital expenditure12 months2021-01-01 to 2021-12-31EUR 397.0mifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
Cash and equivalentsAt period end2021-12-31EUR 2.30bnifrs-full:CashAndCashEquivalents
Current assetsAt period end2021-12-31EUR 10.35bnifrs-full:CurrentAssets
Total assetsAt period end2021-12-31EUR 30.96bnifrs-full:Assets
Current liabilitiesAt period end2021-12-31EUR 7.45bnifrs-full:CurrentLiabilities
Shareholders' equityAt period end2021-12-31EUR 14.44bnifrs-full:EquityAttributableToOwnersOfParent
Shares outstandingAt period end2021-12-31870,182,445 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0000313216-22-000008. Last ingested by Listed: Nov 3, 2026, 08:26 ET. Listed shows no prices and gives no investment advice.